National Notifiable Diseases Surveillance System tables,1 October and 31 December 2012

A summary of diseases currently being reported by each jurisdiction for the reporting period.

Page last updated: 20 May 2013

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 45,254 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 October and 31 December 2012 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Disease Data received from:
Bloodborne diseases
Hepatitis (NEC) All jurisdictions
Hepatitis B (newly acquired) All jurisdictions
Hepatitis B (unspecified) All jurisdictions
Hepatitis C (newly acquired) All jurisdictions except Queensland
Hepatitis C (unspecified) All jurisdictions
Hepatitis D All jurisdictions
Gastrointestinal diseases
Botulism All jurisdictions
Campylobacteriosis All jurisdictions except New South Wales
Cryptosporidiosis All jurisdictions
Haemolytic uraemic syndrome All jurisdictions
Hepatitis A All jurisdictions
Hepatitis E All jurisdictions
Listeriosis All jurisdictions
STEC, VTEC* All jurisdictions
Salmonellosis All jurisdictions
Shigellosis All jurisdictions
Typhoid All jurisdictions
Quarantinable diseases
Cholera All jurisdictions
Highly pathogenic avian influenza in humans All jurisdictions
Plague All jurisdictions
Rabies All jurisdictions
Severe acute respiratory syndrome All jurisdictions
Smallpox All jurisdictions
Viral haemorrhagic fever All jurisdictions
Yellow fever All jurisdictions
Sexually transmissible infections
Chlamydial infection All jurisdictions
Donovanosis All jurisdictions
Gonococcal infection All jurisdictions
Syphilis - congenital All jurisdictions
Syphilis <2 years duration All jurisdictions
Syphilis >2 years or unspecified duration All jurisdictions except South Australia
Vaccine preventable diseases
Diphtheria All jurisdictions
Haemophilus influenzae type b All jurisdictions
Influenza (laboratory confirmed) All jurisdictions
Measles All jurisdictions
Mumps All jurisdictions
Pertussis All jurisdictions
Pneumococcal disease (invasive) All jurisdictions
Poliomyelitis All jurisdictions
Rubella All jurisdictions
Rubella - congenital All jurisdictions
Tetanus All jurisdictions
Varicella zoster (chickenpox) All jurisdictions except New South Wales
Varicella zoster (shingles) All jurisdictions except New South Wales
Varicella zoster (unspecified) All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC) All jurisdictions
Barmah Forest virus infection All jurisdictions
Dengue virus infection All jurisdictions
Japanese encephalitis virus infection All jurisdictions
Kunjin virus infection All jurisdictions
Malaria All jurisdictions
Murray Valley encephalitis virus infection All jurisdictions
Ross River virus infection All jurisdictions
Zoonoses
Anthrax All jurisdictions
Australian bat lyssavirus All jurisdictions
Brucellosis All jurisdictions
Leptospirosis All jurisdictions
Lyssavirus (NEC) All jurisdictions
Ornithosis All jurisdictions
Q fever All jurisdictions
Tularaemia All jurisdictions
Other bacterial infections
Legionellosis All jurisdictions
Leprosy All jurisdictions
Meningococcal infection All jurisdictions
Tuberculosis All jurisdictions

* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).

NEC Not elsewhere classified.

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 October to 31 December 2012, by date of diagnosis*

Disease State or territory Total 3rd quarter 2012 Total 2nd quarter 2012 Total 3rd quarter 2011 Last 5 years mean 3rd quarter Ratio†† Year to date 2012 Last 5 years YTD mean
ACT NSW NT Qld SA Tas. Vic. WA
Bloodborne diseases
Hepatitis (NEC) 0 0 0 0 0 0 3 0 3 0 1 0.4 7.5 3 0.4
Hepatitis B (newly acquired) 0 8 1 16 3 1 10 9 48 48 52 57.0 0.8 184 243.6
Hepatitis B (unspecified) 25 512 39 186 72 19 302 217 1,372 1,755 1,571 1,628.4 0.8 6,358 6,754.8
Hepatitis C (newly acquired) 1 15 0 NN 16 5 36 40 113 103 87 94.6 1.2 437 389.0
Hepatitis C (unspecified) 31 736 68 605 74 63 500 277 2,354 2,471 2,318 2,606.4 0.9 9,643 10,847.8
Hepatitis D 0 2 0 2 1 0 1 0 6 5 4 6.8 0.9 28 35.8
Gastrointestinal diseases
Botulism 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.8
Campylobacteriosis 101 NN 36 1,018 444 267 928 528 3,322 3,686 4,367 4,559.8 0.7 15,078 16,656.8
Cryptosporidiosis 1 136 14 92 12 5 77 59 396 332 412 466.4 0.8 3,094 2,544.2
Haemolytic uraemic syndrome 0 0 0 1 0 0 3 0 4 3 4 5.4 0.7 18 17.2
Hepatitis A 0 15 0 7 2 1 15 2 42 39 40 83.6 0.5 163 283.6
Hepatitis E 0 4 0 1 0 0 2 0 7 5 9 5.6 1.3 35 34.6
Listeriosis 0 12 0 2 0 1 7 3 25 18 22 17.0 1.5 92 70.2
STEC, VTEC§ 0 3 0 12 11 1 4 1 32 19 36 34.2 0.9 110 101.2
Salmonellosis 59 825 78 664 154 71 657 272 2,780 2,024 2,907 2,508.6 1.1 11,217 10,289.8
Shigellosis 2 32 19 23 3 2 31 15 127 106 140 150.0 0.8 544 617.0
Typhoid fever 0 12 0 5 1 0 6 7 31 15 31 23.8 1.3 122 108.0
Quarantinable diseases
Cholera 0 0 0 0 0 0 3 0 3 2 1 1.4 2.1 10 5.0
Highly pathogenic avian influenza in humans 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Plague 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rabies 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Severe acute respiratory syndrome 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Smallpox 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Viral haemorrhagic fever 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Yellow fever 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 2.0
Sexually transmissible infections
Chlamydial infection||** 304 4,916 542 4,529 1,041 406 1,231 2,781 15,750 19,979 19,608 16,003.8 1.0 78,616 65,700.0
Donovanosis 0 0 0 0 0 0 0 0 0 1 0 0.0 0.0 1 1.4
Gonococcal infection|| 26 960 351 652 78 14 460 530 3,071 3,090 3,202 2,298.0 1.3 13,232 9,188.0
Syphilis – congenital 0 0 0 0 0 0 0 0 0 0 1 1.4 0.0 1 5.2
Syphilis < 2 years|| 4 48 3 70 22 2 85 24 258 393 307 299.4 0.9 1,415 1,302.8
Syphilis > 2 years or unspecified duration‡|| 5 29 15 50 NN 6 136 20 261 316 320 320.4 0.8 1,196 1,333.8
Vaccine preventable diseases
Diphtheria 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.8
Haemophilus influenzae type b 0 0 0 2 0 0 1 0 3 5 2 4.4 0.7 15 19.8
Influenza (laboratory confirmed) 40 479 66 789 859 35 547 220 3,035 32,877 2,905 2,012.6 1.5 44,525 23,887.4
Measles 0 20 1 0 3 0 0 5 29 129 50 14.4 2.0 199 88.8
Mumps 0 11 0 10 4 1 7 4 37 48 42 86.8 0.4 192 257.0
Pertussis 168 1,143 38 2,158 218 453 1,015 456 5,649 5,458 10,336 8,144.6 0.7 23,677 24,478.2
Pneumococcal disease (invasive) 7 120 10 63 23 9 82 43 357 719 386 348.6 1.0 1,811 1,635.8
Poliomyelitis 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.2
Rubella 0 0 0 2 0 0 3 0 5 8 8 6.0 0.8 35 39.8
Rubella congenital 0 0 0 0 0 0 0 0 0 1 0 0.0 0.0 1 0.4
Tetanus 0 1 0 1 0 0 1 0 3 2 0 0.2 15.0 6 3.0
Varicella zoster (chickenpox) 3 NN 28 44 120 4 199 88 486 597 651 586.0 0.8 1,939 1,811.8
Varicella zoster (shingles) 18 NN 39 17 443 49 278 279 1,123 1,069 1,068 733.6 1.5 4,397 2,718.4
Varicella zoster (unspecified) 35 NN 0 1,208 93 26 705 292 2,359 2,051 2,177 1,692.2 1.4 8,512 6,068.8
Vectorborne diseases
Arbovirus infection (NEC) 0 0 0 8 0 0 0 0 8 2 8 5.4 1.5 16 16.8
Barmah Forest virus infection 1 101 42 374 22 0 11 86 637 279 345 368.4 1.7 1,701 1,718.6
Dengue virus infection 7 50 3 44 8 1 38 35 186 193 213 216.4 0.9 1,481 863.2
Japanese encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 1 0.2
Kunjin virus infection 0 0 0 0 0 0 0 0 0 0 1 0.4 0.0 0 1.6
Malaria 3 16 7 26 2 1 12 17 84 99 110 112.6 0.7 325 479.0
Murray Valley encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 1 0.2 0.0 1 4.4
Ross River virus infection 2 103 44 330 41 0 56 103 679 483 747 926.6 0.7 4,651 4,956.0
Zoonoses
Anthrax 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.4
Australian bat lyssavirus 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Brucellosis 0 1 0 6 1 0 0 0 8 9 9 8.0 1.0 25 34.8
Leptospirosis 0 2 0 2 1 0 1 2 8 11 21 22.4 0.4 111 141.2
Lyssavirus (NEC) 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Ornithosis 0 1 0 1 1 0 21 3 27 14 26 23.0 1.2 65 81.2
Q fever 0 21 2 31 0 0 1 1 56 80 97 91.8 0.6 318 361.0
Tularaemia 0 0 0 0 0 0 0 0 0 0 1 1.0 0.0 0 2.0
Other bacterial infections
Legionellosis 1 12 0 19 9 3 17 28 89 97 100 83.8 1.1 367 305.2
Leprosy 0 0 0 0 0 0 1 0 1 1 3 3.0 0.3 3 9.8
Meningococcal disease (invasive)‡‡ 0 9 0 12 5 2 7 3 38 83 49 62.4 0.6 222 264.2
Tuberculosis 3 96 7 39 21 2 126 48 342 302 390 384.2 0.9 1,202 1,282.8
 Total 847 10,451 1,453 13,121 3,808 1,450 7,626 6,498 45,254 79,027 55,186     237,395  

* Date of diagnosis is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results) or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.

† Newly-acquired hepatitis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.

§ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.

|| In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.

** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.

†† Ratios of the current quarter to the mean of the last 5 quarters (ratios for Varicella are based on 4 years data)

‡‡ Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Top of page

Table 3. Notification rates of diseases, 1 October to 31 December 2012, by date of diagnosis and state or territory (Annualised rate per 100,000 population)*

Table 3. Notification rates of diseases, 1 October to 31 December 2012, by date of diagnosis and state or territory (Annualised rate per 100,000 population)*

Disease ACT NSW NT Qld SA Tas. Vic. WA Aust
Bloodborne diseases
Hepatitis (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1
Hepatitis B (newly acquired) 0.0 0.4 1.7 1.4 0.7 0.8 0.7 1.5 0.8
Hepatitis B (unspecified)§ 27.4 28.0 67.7 16.2 17.4 14.9 21.5 36.9 24.3
Hepatitis C (newly acquired) 1.1 0.8 0.0 NN 3.9 3.9 2.6 6.8 2.5
Hepatitis C (unspecified)§ 33.9 40.3 118.1 52.8 17.9 49.4 35.6 47.2 41.6
Hepatitis D 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1
Gastrointestinal diseases
Botulism 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Campylobacteriosis 110.5 NN 62.5 88.9 107.2 209.2 66.0 89.9 86.8
Cryptosporidiosis 1.1 7.4 24.3 8.0 2.9 3.9 5.5 10.0 7.0
Haemolytic uraemic syndrome 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1
Hepatitis A 0.0 0.8 0.0 0.6 0.5 0.8 1.1 0.3 0.7
Hepatitis E 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1
Listeriosis 0.0 0.7 0.0 0.2 0.0 0.8 0.5 0.5 0.4
STEC, VTEC|| 0.0 0.2 0.0 1.0 2.7 0.8 0.3 0.2 0.6
Salmonellosis 64.5 45.2 135.4 58.0 37.2 55.6 46.8 46.3 49.2
Shigellosis 2.2 1.8 33.0 2.0 0.7 1.6 2.2 2.6 2.2
Typhoid fever 0.0 0.7 0.0 0.4 0.2 0.0 0.4 1.2 0.5
Quarantinable diseases
Cholera 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1
Highly pathogenic avian influenza in humans 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Plague 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rabies 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Severe acute respiratory syndrome 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Smallpox 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viral haemorrhagic fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Yellow fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sexually transmissible infections
Chlamydial infection¶** 332.6 269.3 941.1 395.5 251.4 318.1 87.6 473.5 278.5
Donovanosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Gonococcal infection 28.4 52.6 609.5 56.9 18.8 11.0 32.7 90.2 54.3
Syphilis - congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Syphilis < 2 years 4.4 2.6 5.2 6.1 5.3 1.6 6.0 4.1 4.6
Syphilis > 2 years or unspecified duration 5.5 1.6 26.0 4.4 NN 4.7 9.7 3.4 5.0
Vaccine preventable diseases
Diphtheria 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Haemophilus influenzae type b 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1
Influenza (laboratory confirmed) 43.8 26.2 114.6 68.9 207.5 27.4 38.9 37.5 53.7
Measles 0.0 1.1 1.7 0.0 0.7 0.0 0.0 0.9 0.5
Mumps 0.0 0.6 0.0 0.9 1.0 0.8 0.5 0.7 0.7
Pertussis 183.8 62.6 66.0 188.5 52.6 354.9 72.2 77.6 99.9
Pneumococcal disease (invasive) 7.7 6.6 17.4 5.5 5.6 7.1 5.8 7.3 6.3
Poliomyelitis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1
Rubella - congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tetanus 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1
Varicella zoster (chickenpox) 3.3 NN 48.6 3.8 29.0 3.1 14.2 15.0 12.7
Varicella zoster (shingles) 19.7 NN 67.7 1.5 107.0 38.4 19.8 47.5 29.3
Varicella zoster (unspecified) 38.3 NN 0.0 105.5 22.5 20.4 50.2 49.7 61.6
Vectorborne diseases
Arbovirus infection (NEC) 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1
Barmah Forest virus infection 1.1 5.5 72.9 32.7 5.3 0.0 0.8 14.6 11.3
Dengue virus infection 7.7 2.7 5.2 3.8 1.9 0.8 2.7 6.0 3.3
Japanese encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Kunjin virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Malaria 3.3 0.9 12.2 2.3 0.5 0.8 0.9 2.9 1.5
Murray Valley encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ross River virus infection 2.2 5.6 76.4 28.8 9.9 0.0 4.0 17.5 12.0
Zoonoses
Anthrax 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australian bat lyssavirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Brucellosis 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.1
Leptospirosis 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 0.1
Lyssavirus (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ornithosis 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.5 0.5
Q fever 0.0 1.2 3.5 2.7 0.0 0.0 0.1 0.2 1.0
Tularaemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other bacterial infections
Legionellosis 1.1 0.7 0.0 1.7 2.2 2.4 1.2 4.8 1.6
Leprosy 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Meningococcal disease (invasive)†† 0.0 0.5 0.0 1.0 1.2 1.6 0.5 0.5 0.7
Tuberculosis 3.3 5.3 12.2 3.4 5.1 1.6 9.0 8.2 6.0

* Date of diagnosis = is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results) or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.

† Rate per 100,000 population. The annualisation factor was 4.0.

‡ Newly-acquired hepatitis and syphilis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.

§ Unspecified hepatitis includes cases where the duration of infection could not be determined.

|| Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.

¶ In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.

** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.

†† Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

* Date of diagnosis = is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results) or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.

† Rate per 100,000 population. The annualisation factor was 4.0.

‡ Newly-acquired hepatitis and syphilis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.

§ Unspecified hepatitis includes cases where the duration of infection could not be determined.

|| Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.

¶ In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.

** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.

†† Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

In this section

    Communicable Diseases Intelligence subscriptions

    Sign-up to email updates: Subscribe Now